NCT03277066 - A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis | Biotech Hunter

Enrollment

289

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

September 25, 2019

Study Completion Date

September 25, 2019

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

Diclofenac Sodium Active Topical Patch 1

HP-5000 Active Topical Patch 1 were applied on subjects with Osteoarthritis of the knee(s)

DRUG

Diclofenac Sodium Active Topical Patch 2

HP-5000 Active Topical Patch 2 were applied on subjects with Osteoarthritis of the knee(s)

DRUG

Placebo patch

Topical placebo patches were applied on subjects with Osteoarthritis of the knee(s)

Trial Locations (1)

Noven Pharmaceuticals, Inc., Jersey City